DENTSPLY SIRONA Inc. (XRAY) Expected to Post Earnings of $0.67 Per Share
Brokerages expect DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to announce earnings of $0.67 per share for the current quarter, according to Zacks. Eight analysts have provided estimates for DENTSPLY SIRONA’s earnings, with the lowest EPS estimate coming in at $0.64 and the highest estimate coming in at $0.73. DENTSPLY SIRONA reported earnings of $0.66 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 1.5%. The business is expected to report its next quarterly earnings results on Friday, November 3rd.
According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.68 per share for the current year, with EPS estimates ranging from $2.65 to $2.70. For the next fiscal year, analysts expect that the business will post earnings of $3.01 per share, with EPS estimates ranging from $2.78 to $3.15. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that follow DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same period last year, the company earned $0.76 earnings per share. The company’s revenue for the quarter was down 2.9% on a year-over-year basis.
A number of research analysts recently issued reports on XRAY shares. Stifel Nicolaus restated a “buy” rating and set a $66.00 price objective (down previously from $70.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. HC Wainwright started coverage on DENTSPLY SIRONA in a research report on Tuesday, July 11th. They set a “buy” rating and a $74.00 price objective for the company. BidaskClub upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price objective for the company in a research report on Thursday, July 13th. Finally, Jefferies Group LLC reduced their price objective on DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating for the company in a research report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $65.89.
A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its position in DENTSPLY SIRONA by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 22,728,062 shares of the medical instruments supplier’s stock worth $1,473,688,000 after acquiring an additional 562,993 shares during the period. BlackRock Inc. boosted its position in DENTSPLY SIRONA by 3,103.7% during the 1st quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock worth $867,376,000 after acquiring an additional 13,457,730 shares during the period. State Street Corp boosted its position in DENTSPLY SIRONA by 0.4% during the 1st quarter. State Street Corp now owns 9,931,689 shares of the medical instruments supplier’s stock worth $620,136,000 after acquiring an additional 36,012 shares during the period. Principal Financial Group Inc. boosted its position in DENTSPLY SIRONA by 22.3% during the 2nd quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock worth $419,802,000 after acquiring an additional 1,181,547 shares during the period. Finally, Veritas Asset Management LLP boosted its position in DENTSPLY SIRONA by 2.6% during the 2nd quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock worth $402,083,000 after acquiring an additional 157,616 shares during the period. Institutional investors own 93.87% of the company’s stock.
Shares of DENTSPLY SIRONA (XRAY) traded down 0.17% during midday trading on Friday, hitting $59.40. The company had a trading volume of 937,133 shares. The company’s market cap is $13.63 billion. The stock’s 50-day moving average price is $57.94 and its 200-day moving average price is $61.07. DENTSPLY SIRONA has a 12 month low of $52.54 and a 12 month high of $65.68.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.